Resolian · 2 days ago
Associate Scientist II Immunoassay
Resolian is a leading global Contract Research Organization that is expanding rapidly and delivering best in class service to its clients. The Associate Scientist II Immunoassay will prepare reagents, analyze samples, assist with method development, and ensure compliance with regulatory requirements.
BiotechnologyPharmaceutical
Responsibilities
Prepare reagents, standards, and control samples
Analyze samples using various techniques specific to department
Assist with method development
Perform method validation or qualification
Operate analytical equipment
Lead troubleshooting activities
Maintain analytical equipment
Ensure lab area is clean and inspection ready at all times
Remove lab waste
Record tasks in accordance with Good Documentation Practices (GDP)
Understand and apply regulatory requirements; GLP, GCP, 21CFR Part 11
Follow applicable SOPs and procedural documents
Review and evaluate data results
Train lower level Scientists
Other tasks as assigned
Qualification
Required
BA/BS or higher with 4-6 years lab experience; all experiences will be evaluated
Able to perform complex lab work
Experience working in a regulated environment
ELISA, MSD experience or pipetting efficiency needed
Ligand binding/ immunoassay experience
Able to work effectively and contribute within a team
Able to work with computer systems
Able to document clearly; Knowledge of and experience in a regulatory environment
Preferred
CRO experience preferred
Company
Resolian
Resolian is a multinational bioanalytical contract research organization (CRO) focusing on medication metabolism.
H1B Sponsorship
Resolian has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2024 (1)
Funding
Current Stage
Late StageTotal Funding
unknown2022-05-17Private Equity
Recent News
Company data provided by crunchbase